Latest Competition News

Page 14 of 531
Pepper Money is set to become the servicer for a massive A$36 billion loan portfolio from HSBC Australia following its acquisition by a Blackstone-controlled entity, aligning with Pepper Money's strategy to expand its capital-light servicing business.
Claire Turing
Claire Turing
31 July 2026
OpenLearning Limited posted a record $3.27 million in SaaS annual recurring revenue and its highest quarterly cash receipts of $1.653 million, driven by new multi-year contracts in the Philippines and Malaysia and launches of AI-driven student recruitment and employability platforms.
Sophie Babbage
Sophie Babbage
31 July 2026
Meteoric Resources has completed a Definitive Feasibility Study for its Caldeira Rare Earth Project in Brazil, revealing a large, high-grade ionic clay deposit with a 20-plus year mine life and strong financial metrics.
Maxwell Dee
Maxwell Dee
31 July 2026
NH3 Clean Energy has secured Federal Major Project Status for its WAH2 clean ammonia project, backed by a Linde Engineering FEED agreement and a robust public benefits forecast supporting government-backed financing.
Maxwell Dee
Maxwell Dee
31 July 2026
Galilee Energy has commenced drilling its Zydeco-1 well in Louisiana, executing a cost-optimised plan targeting up to 13.7 billion cubic feet of gas and 610,000 barrels of condensate, marking a key milestone in its US Gulf Coast expansion.
Maxwell Dee
Maxwell Dee
31 July 2026
Zelira Therapeutics has raised nearly US$33 million into its HOPE® 1 special purpose vehicle, valuing the SPV at about US$66 million post-money. The funds will advance FDA regulatory submissions and Phase 1 clinical trials for its autism-targeting cannabinoid drug.
Ada Torres
Ada Torres
30 July 2026
Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial stays on track for November topline results, buoyed by strong open-label extension enrolment and aligned EMA-FDA regulatory advice. A new antidepressant study publication and fresh patents add momentum, supported by a $16.7 million cash runway to mid-2027.
Ada Torres
Ada Torres
30 July 2026
Alterity Therapeutics has cleared a major regulatory hurdle with the FDA endorsing a single pivotal Phase 3 trial for its ATH434 drug in Multiple System Atrophy, setting the stage for trial initiation by the end of 2026.
Ada Torres
Ada Torres
30 July 2026
Cann Group reported its second-ever quarterly operating cash inflow of $0.24 million in Q4 FY2026, edging closer to cash flow break-even. The company expanded exports to the UK and Germany, launched new products, and completed a leadership transition while redeeming convertible notes and securing additional credit.
Ada Torres
Ada Torres
30 July 2026
Betr Entertainment reported its first positive operating cash flow since 2021 with $2.6 million in Q4 FY26, driven by improved customer engagement and promotional efficiency. The company enters FY27 with strong momentum, including over 15% turnover growth in July excluding World Cup effects and record Same Game Multi volumes.
Sophie Babbage
Sophie Babbage
30 July 2026
Raiz Invest reported robust Q4 FY26 growth with active customers climbing 6.7% and funds under management hitting $2.32 billion, while confirming FY26 profitability guidance.
Claire Turing
Claire Turing
30 July 2026
Horizon Gold's Definitive Feasibility Study for the Gum Creek Project outlines a 10-year open pit mine with robust production targets, strong financial metrics, and significant exploration progress, backed by a $30 million capital raise.
Maxwell Dee
Maxwell Dee
30 July 2026

Browse the archive

Full archive